Oncology

A newly published knowledgebase and web portal from the George Washington University, OncoMX, will foster a dynamic engagement between bioinformaticians and cancer biomarker researchers

Current efforts and obstacles for use of next-generation sequencing in routine oncology practice

NCCN Quality and Outcomes Committee’s endorsements of impactful and feasible quality and outcomes measures offer opportunities to advance the quality of cancer care in America

Researchers have developed an innovative diagnostic assay to identify cells resistant to leukemia treatment

Recent discovery helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies 

The expansion of immunotherapies is a key trend to watch in cancer research

The genomically-adjusted radiation dose (GARD) can predict risk of local tumor recurrence and optimize radiation dose

Some of the latest innovations in cancer treatment and diagnosis

Forty percent of patients with diffuse large B-cell lymphoma had a complete response, most of which were durable

Drug is the first to target common mutation associated with relapse and short survival in AML